nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.12.2007 | Guidelines

Sentinel node in breast cancer procedural guidelines

verfasst von: John Buscombe, Giovanni Paganelli, Zeynep E. Burak, Wendy Waddington, Jean Maublant, Enrique Prats, Holger Palmedo, Orazio Schillaci, Lorenzo Maffioli, M. Lassmann, Carlo Chiesa, Emilio Bombardieri, Arturo Chiti, On behalf of the European Association of Nuclear Medicine Oncology Committee and Dosimetry Committee

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Abstract

Content

Procedure guidelines for scintigraphic detection of sentinel node in breast cancer are presented.

Authors

The paper was written by several experts in this field on behalf of the European Association of Nuclear Medicine Oncology and Dosimetry committees and approved by the Executive Committee.

Keshtgar MRS, Ell PJ. Sentinel lymph node detection and imaging. Eur J Nucl Med 1999;26:57–67.PubMedCrossRef

Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546–53.PubMedCrossRef

Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomized controlled study. Lancet Oncol 2006;7:983–90.PubMedCrossRef

De Cicco C, Cremonesi M, Luini A, Bartolomei M, Grana C, Prisco G, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998; 39:2080–4.PubMed

Amersi F, Hansen NM. The benefits and limitations of sentinel lymph node biopsy. Curr Treat Options Oncol 2006;7:141–51.PubMedCrossRef

Keleher A, Wendt R 3rd, Delpassand E, Stachowiak AM, Kuerer HM. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulphur colloid. Breast J 2004;10:492–5.PubMedCrossRef

Morita ET, Chang J, Leong SP. Principles and controversies in lymphoscintigraphy with emphasis on breast cancer. Surg Clin North Am 2000;80:1721–39.PubMedCrossRef

Gentilini O, Cremonesi M, Trifirò G, Ferrari M, Baio SM, Caracciolo M, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348–51.PubMedCrossRef

Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer—a multi-center validation study. N Engl J Med 1998;339:941–6.PubMedCrossRef

10.

Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703–20.PubMedCrossRef

11.

NEMA. NU 1 2001 Performance Measurements of Scintillation Cameras. Rosslyn: National Electrotechnical Manufacturers Association; 2001 (http://www.nema.org/stds/nu1.cfm).

12.

IEC. IEC/TR 61948-2 Ed. 1.0 en:2001 Nuclear medicine instrumentation—routine tests—part 2: scintillation cameras and single photon emission computed tomography imaging. Geneva: International Electrotechnical Commission; 2001.

13.

NEMA. NU 3 2004 Performance measurements and quality control guidelines for non-imaging intraoperative gamma probes. Rosslyn: National Electrotechnical Manufacturers Association; 2004 ( http://www.nema.org/stds/nu3.cfm ).

14.

Mariani G, Moresco I, Viale G, Villa G, Bagnasco M, Canavese G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001;42:1198–215.PubMed

15.

Bourgeois P. Scintigraphic investigations of the lymphatic system: the influence of injected volume and quantity of labeled colloidal tracer. J Nucl Med 2007;48:693–5.PubMedCrossRef

16.

Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer patients with clinically negative lymph-nodes. Lancet 1997;349:1864–7.PubMedCrossRef

17.

Law M, Cheng KC, Wu PM, Ho WY, Chow LW. Patient effective dose from sentinel lymph node lymphoscintigraphy in breast cancer: a study using a female humanoid phantom and thermoluminescent dosimeters. Br J Radiol 2003;76:818–23.PubMedCrossRef

18.

Waddington WA, Keshtgar MRS, Taylor I, Lakhani SR, Short MD, Ell PJ. Radiation safety of the sentinel node technique in breast cancer. Eur J Nucl Med 2000;27:377–91.PubMedCrossRef

19.

Cremonesi M, Ferrari M, Sacco E, Rossi A, De Cicco C, Leonardi L, et al. Radiation protection in radioguided surgery of breast cancer. Nucl Med Commun 1999;20:919–24.PubMed

20.

Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RP, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloid albumin in breast cancer. J Nucl Med 1997;38:366–8.

21.

Pelosi E, Bello M, Griors M, Ala A, Giani R, Bussone R, et al. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques. J Nucl Med 2004;45:220–5.PubMed

22.

Chakera AH, Friis E, Hesse U, Al-Suliman N, Zerahn B, Hesse B. Factors of importance for scintigraphic non-visualization of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging 2005;32:286–93.PubMedCrossRef

23.

Zanzonico P, Heller S. The intraoperative gamma probe: basic principles and choices available. Semin Nucl Med 2000;1:33–48.CrossRef

24.

International Electrotechnical Commission. Medical electrical equipment—part 1: general requirements for safety. IEC 60101-1. (1988-12). Geneva: IEC; 1988.

25.

Paganelli G, Galimberti V, Trifirò G, Travaini L, De Cicco C, Mazzarol G, et al. Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med 2002;46:138–44.PubMed

26.

Clarke D, Khoni N, Mansel ER. Sentinel node biopsy in breast cancer. ALMANAC trial. World J Surg 2001;25:819–22.PubMedCrossRef

27.

Luini A, Galimberti V, Gatti G, Arnone P, Vento AR, Trifiro G, et al. The sentinel node biopsy after previous breast surgery; preliminary results on 543 patients treated at EIO. Breast Cancer Res Treat 2005;89:159–63.PubMedCrossRef

28.

Schwartz GF, Meltzer AJ. Accuracy of sentinel node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 2003;9:374–9.PubMedCrossRef

29.

Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B, et al. Retrospective analysis of sentinel node localization in multifocal multicentric, palpable, or non palpable breast cancer. J Nucl Med 2003;44:7–10.PubMed

30.

Knauer M, Konstantiniuk P, Haid A, Wenzl E, Riegler-Keil M, Postlberger S, et al. Multicentric breast cancer: a new indication for sentinel node biopsy—a multi institutional validation study. J Clin Oncol 2006;24:3374–80.PubMedCrossRef

Titel: Sentinel node in breast cancer procedural guidelines
verfasst von: John Buscombe
Giovanni Paganelli
Zeynep E. Burak
Wendy Waddington
Jean Maublant
Enrique Prats
Holger Palmedo
Orazio Schillaci
Lorenzo Maffioli
M. Lassmann
Carlo Chiesa
Emilio Bombardieri
Arturo Chiti
On behalf of the European Association of Nuclear Medicine Oncology Committee and Dosimetry Committee
Publikationsdatum: 01.12.2007
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2007
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-007-0614-z

Springer Medizin

Abstract

Content

Authors

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2007

FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading

Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma

Functional sex differences in human primary auditory cortex

What can gallium-68 PET add to receptor and molecular imaging?

Classic tumour imaging agents for glioma evaluation: 99mTc-tetrofosmin

In vivo fluorescence imaging of the reticuloendothelial system using quantum dots in combination with bioluminescent tumour monitoring